SCHEMBL741585

SCHEMBL741585

O=c1ccc2nc3c(oc-2c1)CCC=C3

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APP P05067 12/20 0.40
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10352693 0.92 APP (0.39) APPCYP1A2
SCHEMBL8067 0.67 APP (0.65) APPCYP1A2
SCHEMBL9819993 0.66
SCHEMBL1096453 0.66 APP (0.63) APPCYP1A2
Water SCHEMBL1094033 0.66 APP (0.63) APPCYP1A2
SCHEMBL31022115 0.65
Phosphoric Acid SCHEMBL307362 0.62 APP (0.61) APPCYP1A2
Acetic Acid SCHEMBL233001 0.61 APP (0.59) APPCYP1A2
SCHEMBL532224 0.61 APP (0.59) APPCYP1A2
SCHEMBL16168626 0.61 RAB9A (0.41) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114746741-A Monitoring cellular metabolic activity using resorufin under anaerobic conditions 分离生物公司 2022-07-12 CN claimed
US-20210115367-A1 Use of Resorufin for Monitoring Metabolic Activity of Cells under Anaerobic Condition ISOLATION BIO INC. 2021-04-22 US claimed
US-20200325518-A1 Systems and Methods for Metabolic Assessment Utilizing 1-Methoxy-PMS Field OXFORD FINANCE LLC 2020-10-15 US claimed
US-20190316169-A1 METHODS, COMPOSITIONS, AND KITS FOR DETECTING A CELL IN A SAMPLE SONANUTECH INC. (US) 2019-10-17 US claimed
US-20190300927-A1 METABOLIC ASSAY FOR BACTERIAL GROWTH AND GRAM TYPING OXFORD FINANCE LLC 2019-10-03 US claimed
US-20190271693-A1 METHODS, COMPOSITIONS, AND KITS FOR DETECTING BACTERIOPHAGE IN A SAMPLE SONANUTECH INC. (US) 2019-09-05 US claimed
WO-2018098404-A1 METHODS, COMPOSITIONS, AND KITS FOR DETECTING A CELL IN A SAMPLE SONANUTECH INC. (US) 2018-05-31 WO claimed
WO-2018098402-A1 METHODS, COMPOSITIONS, AND KITS FOR DETECTING BACTERIOPHAGE IN A SAMPLE SONANUTECH INC. (US) 2018-05-31 WO claimed
EP-1578999-B1 METHOD FOR MEASURING NON-TRANSFERRIN BOUND IRON YISSUM RES DEV CO (IL) 2013-01-16 EP claimed
WO-2012137202-A1 COMPOSITION COMPRISING AN IRON INDICATOR ATTACHED TO A MICROPARTICLE AND USES OF SAME FOR QUANTIFYING NON-TRANSFERRIN BOUND IRON (NTBI) AND CELLULAR LABILE IRON (LCI) YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2012-10-11 WO claimed
EP-1501938-B1 ANALYSIS OF SUBSTRATE UTILIZATION BY ANIMAL OR PLANT CELLS BIOLOG INC (US) 2009-10-21 EP claimed
US-20070100358-A2 A Biomimetic Synthetic Nerve Implant TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN (US) 2007-05-03 US claimed
US-20070010831-A1 Biomimetic biosynthetic nerve implant ROMERO-ORTEGA MARIO I 2007-01-11 US claimed
EP-1501938-A4 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG INC (US) 2007-01-03 EP claimed
WO-2005046457-A2 A BIOMIMETIC BIOSYNTHETIC NERVE IMPLANT TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN (US) 2005-05-26 WO claimed
EP-1501938-A2 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG, INC. (US) 2005-02-02 EP claimed
WO-2003089652-A2 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG, INC. (US) 2003-10-30 WO claimed
US-20030162164-A1 Comparative phenotype analysis of cells, including testing of biologically active compounds BIOLOG, INC. 2003-08-28 US claimed
US-20030104491-A1 Molecules and methods using same for measuring non-transferrin bound iron YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2003-06-05 US claimed
EP-0210559-B1 N-ACYLDIHYDRORESORUFIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AS WELL AS THEIR USE FOR THE DETERMINATION OF HYDROGEN PEROXIDE, PEROXIDATICALLY ACTIVE COMPOUNDS, OR PEROXIDASE Roche Diagnostics GmbH (DE) 1991-09-25 EP claimed